About DaVita Inc.
https://www.davita.comDaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
CEO
Javier J. Rodriguez
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2013-09-09 | Forward | 2:1 |
| 2004-06-16 | Forward | 3:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 428
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
BERKSHIRE HATHAWAY INC
Shares:32.16M
Value:$3.34B
BLACKROCK INC.
Shares:4.94M
Value:$513.24M
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
Shares:4.34M
Value:$450.72M
Summary
Showing Top 3 of 803
About DaVita Inc.
https://www.davita.comDaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $3.42B ▲ | $581.7M ▲ | $150.33M ▼ | 4.4% ▼ | $2.09 ▼ | $636.85M ▼ |
| Q2-2025 | $3.38B ▲ | $580.14M ▲ | $199.34M ▲ | 5.9% ▲ | $2.62 ▲ | $689.69M ▲ |
| Q1-2025 | $3.22B ▼ | $544.93M ▲ | $162.92M ▼ | 5.05% ▼ | $2.05 ▼ | $597.84M ▼ |
| Q4-2024 | $3.29B ▲ | $503.95M ▼ | $259.33M ▲ | 7.87% ▲ | $3.18 ▲ | $726.56M ▲ |
| Q3-2024 | $3.26B | $576.84M | $214.69M | 6.58% | $2.56 | $695.03M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $736.48M ▼ | $17.74B ▲ | $16.22B ▲ | $-571.87M ▼ |
| Q2-2025 | $739.43M ▲ | $17.49B ▲ | $15.94B ▲ | $-369.63M ▼ |
| Q1-2025 | $511.94M ▼ | $17.12B ▼ | $15.46B ▲ | $-267.1M ▼ |
| Q4-2024 | $846M ▼ | $17.29B ▼ | $15.19B ▼ | $121.12M ▼ |
| Q3-2024 | $1.09B | $17.5B | $15.28B | $386.71M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $309.55M ▲ | $841.37M ▲ | $-262.94M ▼ | $-581.59M ▼ | $-1.54M ▼ | $675.29M ▲ |
| Q2-2025 | $275.22M ▲ | $324.39M ▲ | $-66.75M ▲ | $3.87M ▲ | $272.39M ▲ | $203.3M ▲ |
| Q1-2025 | $162.92M ▼ | $180.01M ▼ | $-162.14M ▲ | $-382.54M ▲ | $-355.25M ▼ | $36.75M ▼ |
| Q4-2024 | $349.25M ▲ | $547.63M ▼ | $-247.97M ▼ | $-565.1M ▼ | $-278.82M ▼ | $376.97M ▼ |
| Q3-2024 | $295.76M | $810.4M | $-146.49M | $-7.86M | $655.4M | $671.36M |
Revenue by Products
| Product | Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 |
|---|---|---|---|---|
 U S Dialysis And Related Lab Services | $2.84Bn ▲ | $2.91Bn ▲ | $5.66Bn ▲ | $1.61Bn ▼ |
CEO
Javier J. Rodriguez
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2013-09-09 | Forward | 2:1 |
| 2004-06-16 | Forward | 3:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 428
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
BERKSHIRE HATHAWAY INC
Shares:32.16M
Value:$3.34B
BLACKROCK INC.
Shares:4.94M
Value:$513.24M
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
Shares:4.34M
Value:$450.72M
Summary
Showing Top 3 of 803